NASDAQ:MLYS
Jefferies initates Mineralys Therapeutics Inc (MLYS) rating to a Hold
In a filing, Mineralys Therapeutics Inc revealed its Director Slingsby Brian Taylor unloaded Company’s shares for reported $43.35 million on ...
Jefferies analysts initates a Hold rating for Mineralys Therapeutics Inc (MLYS)
Mineralys Therapeutics Inc’s recent filing unveils that its Director Slingsby Brian Taylor unloaded Company’s shares for reported $43.35 million on ...
Keeping an Eye on Mineralys Therapeutics Inc (MLYS) After Insider Trading Activity
Mineralys Therapeutics Inc’s recently made public that its Director Slingsby Brian Taylor unloaded Company’s shares for reported $43.35 million on ...
Mineralys Therapeutics Inc (MLYS) rating initates by Jefferies
Mineralys Therapeutics Inc’s recently made public that its CFO and Secretary Levy Adam Scott unloaded Company’s shares for reported $5.36 ...
Understanding the Risks of Investing in Mineralys Therapeutics Inc (MLYS)
Mineralys Therapeutics Inc’s filing revealed that its CFO and Secretary Levy Adam Scott unloaded Company’s shares for reported $0.45 million ...
Mineralys Therapeutics Inc (MLYS) receives a Hold rating from Jefferies
Mineralys Therapeutics Inc’s filing revealed that its CFO and Secretary Levy Adam Scott unloaded Company’s shares for reported $0.45 million ...
Checking in on Mineralys Therapeutics Inc (MLYS) after recent insiders movement
Mineralys Therapeutics Inc’s recent filing unveils that its CFO and Secretary Levy Adam Scott unloaded Company’s shares for reported $0.45 ...
